Velarion Records
Free. Unsubscribe any time.

Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics, Inc. filed 4 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 4 transactions and 4,720 shares. 4 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 4 results prints are on file in the same window.

What stands out

Trades in Lyra Therapeutics, Inc. 4

Adoption dates in Lyra Therapeutics, Inc. 1

Results prints in Lyra Therapeutics, Inc. 4

Trades before a print in Lyra Therapeutics, Inc. 0

Interval to Lyra Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Lyra Therapeutics, Inc. states

Filing text: “10b5-1 trading instruction in the award agreement adopted by the Reporting Person on January 1, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.